HOME - Companies - News
 
 
02 June 2026

Himed, Adva Cera Advance Ceramic Manufacturing


Through this partnership, customers working with Himed to design and optimize additive bioceramic implants will have a seamless route from design and planning through scalable production with Adva Cera.

Himed , a pioneering producer of bioceramic materials, and Adva Cera , a leader in advanced ceramic additive manufacturing, today announced a strategic partnership to create a complete development-to-production pathway for 3D-printed calcium phosphate (CaP) components used in dental, orthopedic, and spinal applications. Through this partnership, customers working with Himed to design and optimize additive bioceramic implants will have a seamless route from design and planning through scalable production with Adva Cera.

The partnership builds on Himed’s 2024 launch of its Bioceramics Center of Excellence™ (BCoE), a contract research and development center that enables medtech startups and established manufacturers to leverage Himed’s thirty-five years of materials expertise to refine 3D-printed bioceramic designs before committing to full-scale production. Now, with Adva Cera as a scale-up partner, customers can smoothly transition from prototype to production without requalifying materials, validating a contract manufacturer, restarting development cycles, or making significant capital expenditures in printing infrastructure.

Fully bioceramic implants have long been a focus of research in orthopedics and dentistry. Because calcium phosphate is the mineral phase of bone itself, a CaP implant can bond directly to surrounding tissue in ways inert metals and polymers cannot. Ceramic additive manufacturing has now matured to the point where complex internal geometries with controlled porosity and intricate lattice structures can be printed reliably, and the market is responding: Additive Manufacturing (AM) Research projects the ceramics 3D-printing sector will grow to nearly $900 million by 2033 . But the leap from prototype to qualified, large-scale production remains a practical barrier. The Himed–Adva Cera partnership aims to close this gap.

“Customers who come to the Bioceramics Center of Excellence now have a clear production pathway,” explains Craig Rosenblum, President of Himed. “Partnering with Adva Cera means two leading companies can move customers from a fully optimized 3D-printed implant design into qualified, production-scale ceramic additive manufacturing with the regulatory rigor that goes with it. Their serial production capabilities will allow our customers to bring an exciting new generation of implants to patients.”

The partnership also offers a fully domestic, vertically integrated pathway from R&D through serial production, which is becoming more important to OEMs seeking to reduce dependence on overseas additive manufacturing.

“Himed has built something immensely valuable for the medtech industry: a center where customers can develop bioceramic technologies with the help of a highly specialized team of material scientists,” said Hugh Roberts, President of Adva Cera. “We’re excited to be the scale partner for that work. Our team is set up for serial production of advanced ceramic components, and our near-net-shape capabilities mean parts go quickly from the build plate to finished components. Partnering with Himed is a natural fit.”

Representatives from both companies will discuss the partnership with attendees at this year’s Orthopaedic Manufacturing Technology Exhibition & Conference in Chicago, June 9–11, at booth 522.

Since 1991, Himed has been on the vanguard of bioceramics characterization. With an all-in-one research and production facility in New York, Himed supplies raw calcium phosphate biomaterials for a wide array of applications and provides tailored, biocompatible coating and texturing solutions through its MATRIX® line of surface treatments. Himed is FDA-registered and ISO 13485:2016-certified.

Adva Cera, formerly SiNAPTIC Technologies and a subsidiary of SiNAPTIC Holdings, is a Broomfield, Colorado-based service bureau that leverages additive manufacturing platforms to produce technical ceramic components.

Adva Cera partners with clients across the aerospace, medical, semiconductor, energy, and industrial sectors to produce advanced ceramic components, making parts that feature complex geometries and high-performance ceramic structures that conventional manufacturing methods cannot achieve. Adva Cera is dedicated to advancing the production capabilities of ceramic additive manufacturing, focusing on precision, scalability, and innovation.

Source: https://www.advacera.com/?utm_source=chatgpt.com

Related articles

Roll-out supports parent education, provider communication, and coordinated specialty care at scale


Investment will accelerate InsideDesk’s AI-powered platform, fuel key hires, and extend the company’s leadership in revenue cycle management for dental service organizations.


Three advances from the fastest-growing dental platform, each designed to reduce complexity and give DSOs more control


Yesterday, Coordinated Care, Sea Mar Community Health Centers (Sea Mar), and the University of Washington Office of Minority Affairs & Diversity (OMA&D) announced the selection of


Yesterday, Coordinated Care, Sea Mar Community Health Centers (Sea Mar), and the University of Washington Office of Minority Affairs & Diversity (OMA&D) announced the selection of


Read more

Achievement and service take center stage as the University of Colorado Anschutz School of Dental Medicine honors the Doctor of Dental Surgery (DDS) Class of 2026.


This peer-reviewed oral pathology article summarizes clinical evidence from BMC oral health (2024). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...


Breakthrough innovation delivers natural-looking zirconia crowns and bridges at a fraction of the cost of hand-painted porcelain.


Henry Schein reported strong financial results for the second quarter of 2026, fueled by broad-based sales growth, improved profitability, and continued momentum across its dental


Oral Surgery Management (USOSM), a management services organization that exclusively serves premier oral and maxillofacial surgeons, has selected Jennifer Ellis to serve as chief f


 
 
 
 

 
 
 
 

Most popular

 
 

Events